These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 9194102)

  • 1. Open clinical study of the efficacy and safety of terbinafine cream 1% in children with tinea corporis and tinea cruris.
    Bakos L; Brito AC; Castro LC; Gontijo B; Lowy G; Reis CM; Ribeiro AM; Souza FH; Villar Mdo L; Zaitz C
    Pediatr Infect Dis J; 1997 Jun; 16(6):545-8. PubMed ID: 9194102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Once daily treatment with terbinafine 1% cream (Lamisil) for one week is effective in the treatment of tinea corporis and cruris. A placebo-controlled study.
    Budimulja U; Bramono K; Urip KS; Basuki S; Widodo G; Rapatz G; Paul C
    Mycoses; 2001; 44(7-8):300-6. PubMed ID: 11714065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Terbinafine. An update of its use in superficial mycoses.
    McClellan KJ; Wiseman LR; Markham A
    Drugs; 1999 Jul; 58(1):179-202. PubMed ID: 10439936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study between terbinafine 1% emulsion-gel versus ketoconazole 2% cream in tinea cruris and tinea corporis.
    Bonifaz A; Saúl A
    Eur J Dermatol; 2000 Mar; 10(2):107-9. PubMed ID: 10694308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical antifungal treatments for tinea cruris and tinea corporis.
    El-Gohary M; van Zuuren EJ; Fedorowicz Z; Burgess H; Doney L; Stuart B; Moore M; Little P
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD009992. PubMed ID: 25090020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of tinea cruris with topical terbinafine.
    Greer DL; Jolly HW
    J Am Acad Dermatol; 1990 Oct; 23(4 Pt 2):800-4. PubMed ID: 2229527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of short-duration oral terbinafine for the treatment of tinea corporis or tinea cruris in subjects with HIV infection or diabetes.
    Rich P; Houpt KR; LaMarca A; Loven KH; Marbury TC; Matheson R; Miller B; Smith S; Wolf J;
    Cutis; 2001 Jul; 68(1 Suppl):15-22. PubMed ID: 11499330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-duration therapy with terbinafine 1% cream in dermatophyte skin infections.
    Evans EG; Seaman RA; James IG
    Br J Dermatol; 1994 Jan; 130(1):83-7. PubMed ID: 8305323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of topical terbinafine in the treatment of tinea cruris.
    Millikan LE
    J Am Acad Dermatol; 1990 Oct; 23(4 Pt 2):795-9. PubMed ID: 2229526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of terbinafine 1% solution in the treatment of interdigital tinea pedis and tinea corporis or tinea cruris.
    Lebwohl M; Elewski B; Eisen D; Savin RC
    Cutis; 2001 Mar; 67(3):261-6. PubMed ID: 11270304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of Terbinafine Hydrochloride 1% Cream vs. Sertaconazole Nitrate 2% Cream in Tinea Corporis and Tinea Cruris: A Comparative Therapeutic Trial.
    Choudhary S; Bisati S; Singh A; Koley S
    Indian J Dermatol; 2013 Nov; 58(6):457-60. PubMed ID: 24249898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy, safety and tolerability of terbinafine for Tinea capitis in children: Brazilian multicentric study with daily oral tablets for 1,2 and 4 weeks.
    Filho ST; Cucé LC; Foss NT; Marques SA; Santamaria JR
    J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):141-6. PubMed ID: 9784040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of topical sertaconazole versus topical terbinafine in localized dermatophytosis: A randomized, observer-blind, parallel group study.
    Chatterjee D; Ghosh SK; Sen S; Sarkar S; Hazra A; De R
    Indian J Pharmacol; 2016; 48(6):659-664. PubMed ID: 28066103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative double-blind study of terbinafine (Lamisil) and griseofulvin in tinea corporis and tinea cruris.
    del Palacio Hernandez A; López Gómez S; González Lastra F; Moreno Palancar P; Iglesias Díez L
    Clin Exp Dermatol; 1990 May; 15(3):210-6. PubMed ID: 2194715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a 1-week, once-daily regimen of terbinafine 1% cream in the treatment of tinea cruris and tinea corporis.
    Zaias N; Berman B; Cordero CN; Hernandez A; Jacobson C; Millikan L; Rojas R; de la Rosa I; Villars V; Birnbaum JE
    J Am Acad Dermatol; 1993 Oct; 29(4):646-8. PubMed ID: 8408803
    [No Abstract]   [Full Text] [Related]  

  • 16. Ajoene in the topical short-term treatment of tinea cruris and tinea corporis in humans. Randomized comparative study with terbinafine.
    Ledezma E; López JC; Marin P; Romero H; Ferrara G; De Sousa L; Jorquera A; Apitz Castro R
    Arzneimittelforschung; 1999 Jun; 49(6):544-7. PubMed ID: 10417874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Terbinafine hydrochloride oral granules versus oral griseofulvin suspension in children with tinea capitis: results of two randomized, investigator-blinded, multicenter, international, controlled trials.
    Elewski BE; Cáceres HW; DeLeon L; El Shimy S; Hunter JA; Korotkiy N; Rachesky IJ; Sanchez-Bal V; Todd G; Wraith L; Cai B; Tavakkol A; Bakshi R; Nyirady J; Friedlander SF
    J Am Acad Dermatol; 2008 Jul; 59(1):41-54. PubMed ID: 18378354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparable efficacy and safety of various topical formulations of terbinafine in tinea pedis irrespective of the treatment regimen: results of a meta-analysis.
    Korting HC; Kiencke P; Nelles S; Rychlik R
    Am J Clin Dermatol; 2007; 8(6):357-64. PubMed ID: 18039018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-week therapy with oral terbinafine in cases of tinea cruris/corporis.
    Farag A; Taha M; Halim S
    Br J Dermatol; 1994 Nov; 131(5):684-6. PubMed ID: 7999601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of 250 mg versus 500 mg oral terbinafine in the treatment of tinea corporis and cruris: A randomised, assessor-blinded comparative study.
    Lal NR; Basu D; Saha A; Ghosh R; Verma R; Bandyopadhyay D
    Indian J Dermatol Venereol Leprol; 2023; 89(5):665-671. PubMed ID: 36688883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.